Boston-Based Ayana Bio and India’s Zenfold Acquire Fermentation Capacity
Key Details:
- Acquisition: Ayana Bio has joined forces with Zenfold Sustainable Technologies to purchase 300,000 liters of fermentation capacity from Meati Foods for $75,000.
- Equipment: The purchase includes twelve 25,000-liter stainless steel fermentation tanks, previously valued in the millions, which will support plant cell culture production in India.
- Impact: This acquisition significantly reduces capital expenditures historically limiting plant cell culture scaling, with operational capacity targeted for early 2027.
Background of Meati Foods:
- Meati Foods, which entered the Assignment for the Benefit of Creditors process in May 2025, faced challenges in scaling mycelium-based meat alternatives. Now, its biomanufacturing infrastructure is being repurposed for different biotechnological applications at a fraction of its original cost.
Understanding Plant Cell Culture
What Is It?
- Plant cell culture is a production method that grows plant cells in bioreactors rather than cultivating whole plants in soil. The process involves manipulating plant tissues into a proliferating state known as a callus.
Advantages:
- The approach offers consistent supply, independence from environmental disruptions, no pesticides or heavy metals, and can achieve higher concentrations of desired compounds compared to traditional agriculture.
Current Focus of Ayana Bio:
- Ayana Bio is focusing on producing high-value ingredients like rosmarinic acid, crocins, and carotenoids, responding to market interest in natural alternatives amid regulatory changes regarding synthetic preservatives.
Importance of the Meati Equipment
Barriers to Scaling:
- High capital costs of fermentation infrastructure have been a major hurdle for scaling synthetic biology. The acquisition of Meati’s tanks presents a unique opportunity for Ayana Bio.
Scaling Approach:
- The 25,000-liter scale represents an essential stepping stone between pilot-scale equipment and larger bioreactors, providing a safer route for scaling up production.
About Zenfold:
- Zenfold, operational since late 2021, focuses on specialty chemicals using innovative methods. The challenges at Meati’s former facility were attributed to real estate and cost structures, not equipment quality.
Future Plans and Challenges
Next Steps:
- The fermentation tanks will be shipped to India, with a dedicated pilot facility for Ayana Bio set to be operational by the first half of 2027. This facility will also serve other plant cell culture companies.
Challenges Ahead:
- The economic viability of plant cell culture must be demonstrated. While the acquisition of affordable equipment addresses capital costs, questions remain about production yields and pricing competitiveness in the market.
This acquisition represents a significant shift in the biotechnology landscape, potentially paving the way for innovative agricultural alternatives and sustainable ingredient production.
